Today, Intellia CSO, @LauraSeppLore, will be at #ASGCT21 speaking about in vivo #CRISPR-based therapeutics during the #GenomeEditing Clinical and Preclinical Updates session. Be sure to tune in! @ASGCTherapy https://t.co/dpkltrcX3y